| Description |
1 online resource (216 pages) |
| Series |
Biotechnology intelligence unit |
|
Biotechnology intelligence unit (Unnumbered)
|
| Contents |
Application of bacterial pathogens in replacement therapy / John R. Tagg, Jeremy P. Burton and Philip A. Wescombe -- Improvement of insect pathogens as insecticides through genetic engineering / Brian A. Federici, Bryony C. Bonning and Raymond J. St Leger -- Phage therapy : a Trojan horse approach to the control of intracellular pathogens / Lawrence Broxmeyer -- Bacterial ghosts as vaccine and drug delivery platforms / Ulrike Beate Mayr [and others] -- In vivo remote control of bacterial vectors for prophylaxis and therapy / Holger Loessner and Siegfried Weiss -- Genetic immunization : bacteria as DNA vaccine delivery vehicles / Pablo Daniel Becker, Miriam Noerder, Carlos Alberto Guzman -- Bacteria mediated gene therapy strategies / Sophie Conchon and Georges Vassaux -- Use of intracellular bacteria for the development of tools for tumor therapy and the detection of novel antibacterial targets / Christoph Schoen [and others] -- Bacterial vectors for RNAi delivery / Thu Nguyen and Johannes H. Fruehauf -- Viral pathogens as therapeutic delivery vehicles / Helen O'Shea -- Promiscuous drugs from pathogenic bacteria in the post-antibiotics era / Arsenio M. Fialho, Tapas K. Das Gupta and Ananda M. Chakrabarty -- Attack and counter-attack : targeted immunomodulation using bacterial virulence factors / Mohammed Bahey-El-Din, Brendan T. Griffin and Cormac G.M. Gahan -- Cosmetic and therapeutic applications of botulinum toxin in the head and neck / Nwanmegha Young and Andrew Blitzer -- The use of recombinant phage lysins for the control of bacterial pathogens / Marianne Horgan [and others] -- Engineered pharmabiotics with improved therapeutic potential / Roy Sleator and Colin Hill |
| Summary |
In 2006, the term 'Patho-biotechnology' was coined to describe the exploitation of pathogens, or pathogen derived factors, for beneficial applications in biotechnology, food and medicine. This concept encompasses three broad areas: (i) The first approach (outlined in Chapters 1-10) involves the use of selected pathogens as effective prophylactic and/or therapeutic agents by replacement technology. The rationale for this "fighting fire with fire" approach being that for most species the strongest niche competitors are often the same or closely related species. (ii) The second approach (outlined |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Microbial biotechnology.
|
|
Pathogenic bacteria -- Therapeutic use
|
|
Bacteria.
|
|
Schizomycetes.
|
|
Genetic Vectors -- therapeutic use
|
|
Bacteria
|
|
Bacterial Toxins -- therapeutic use
|
|
Genetic Therapy -- methods
|
|
MEDICAL -- Microbiology.
|
|
Schizomycetes
|
|
Bacteria
|
|
Microbial biotechnology
|
| Form |
Electronic book
|
| Author |
Sleator, Roy.
|
|
Hill, Colin, PhD.
|
| ISBN |
9781435665064 |
|
1435665066 |
|
9781433711718 |
|
1433711710 |
|
9781587064074 |
|
1587064073 |
|
